Related papers: Pricing the COVID-19 Vaccine: A Mathematical Appro…

Numerous successes have been achieved in combating the COVID-19 pandemic, initially using various precautionary measures like lockdowns, social distancing, and the use of face masks. More recently, various vaccinations have been developed…

We evaluate the efficiency of various heuristic strategies for allocating vaccines against COVID-19 and compare them to strategies found using optimal control theory. Our approach is based on a mathematical model which tracks the spread of…

Most countries have started vaccinating people against COVID-19. However, due to limited production capacities and logistical challenges it will take months/years until herd immunity is achieved. Therefore, vaccination and social distancing…

This study examines the roles of public and private sector actors in the development of mRNA vaccines, a breakthrough innovation in modern medicine. Using a dataset of 151 core patent families and 2,416 antecedent (cited) patents, we…

The COVID-19 pandemic is one of the most pressing issues at present. A question which is particularly important for governments and policy makers is the following: Does the virus spread in the same way in different countries? Or are there…

COVID-19 is a new pandemic disease that is affecting almost every country with a negative impact on social life and economic activities. The number of infected and deceased patients continues to increase globally. Mathematical models can…

The coronavirus disease (COVID-19) has caused enormous disruptions to not only the United States, but also the global economy. Due to the pandemic, issues in the supply chain and concerns about food shortage drove up the food prices.…

Vaccine hesitancy has been a common concern, probably since vaccines were created and, with the popularisation of social media, people started to express their concerns about vaccines online alongside those posting pro- and anti-vaccine…

We present a forecasting analysis on the growth of scientific literature related to COVID-19 expected for 2021. Considering the paramount scientific and financial efforts made by the research community to find solutions to end the COVID-19…

The COVID-19 pandemic has posed a policy making crisis where efforts to slow down or end the pandemic conflict with economic priorities. This paper provides mathematical analysis of optimal disease control policies with idealized…

The debate around vaccines has been going on for decades, but the COVID-19 pandemic showed how crucial it is to understand and mitigate anti-vaccine sentiments. While the pandemic may be over, it is still important to understand how the…

MOOCs have brought unprecedented opportunities of making high-quality courses accessible to everybody. However, from the business point of view, MOOCs are often challenged for lacking of sustainable business models, and academic research…

In this early draft, we describe a decentralized, app-based approach to COVID-19 vaccine distribution that facilitates zero knowledge verification, dynamic vaccine scheduling, continuous symptoms reporting, access to aggregate analytics…

We propose a simple rule of thumb for countries which have embarked on a vaccination campaign while still facing the need to keep non-pharmaceutical interventions (NPI) in place because of the ongoing spread of SARS-CoV-2. If the aim is to…

An epidemiological model for COVID-19 was developed and implemented in MATLAB/GNU Octave for use by public health practitioners, policy makers and the general public. The model distinguishes four stages in the disease: infected, sick,…

Coronavirus disease (COVID-19), which was caused by SARS-CoV-2, has become a global public health concern. A great proportion of the world needs to be vaccinated in order to stop the rapid spread of the disease. In addition to prioritising…

The COVID-19 pandemic fueled one of the most rapid vaccine developments in history. However, misinformation spread through online social media often leads to negative vaccine sentiment and hesitancy. To investigate COVID-19 vaccine-related…

The World Health Organization (WHO) announced that COVID-19 was a pandemic disease on the 11th of March as there were 118K cases in several countries and territories. Numerous researchers worked on forecasting the number of confirmed cases…

Based on the information communicated in press releases, and finally published towards the end of 2020 by Pfizer, Moderna and AstraZeneca, we have built up a simple Bayesian model, in which the main quantity of interest plays the role of…

In this study, we explored how the coronavirus disease (COVID-19) affected the demand for insurance and vaccines in Japan from mid-March to mid-April 2020. Through independent internet surveys, respondents were asked hypothetical questions…